DIAZOXIDE ORAL SOLUTION- diazoxide oral suspension suspension
TriRx Huntsville Pharmaceutical Services LLC
----------
Diazoxide Oral Suspension, USP
DIAZOXIDE ORAL SOLUTION
diazoxide oral suspension suspension |
Product Information |
Product Type | HUMAN PRESCRIPTION DRUG | Item Code (Source) | NDC: 80432-057 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
DIAZOXIDE (UNII: O5CB12L4FN) (DIAZOXIDE - UNII:O5CB12L4FN) | DIAZOXIDE | 50 mg in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 80432-057-06 | 1 in 1 CARTON | 01/06/2023 | |
1 | | 30 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
ANDA | ANDA211050 | 01/06/2023 | |
|
Labeler - TriRx Huntsville Pharmaceutical Services LLC
(117090286)
|
Establishment |
Name | Address | ID/FEI | Business Operations |
TriRx Huntsville Pharmaceutical Services, LLC | | 117090286 | manufacture(80432-057) |
TriR